MEDS

Trxade Group

MEDS42

$7.49arrow_drop_up0.52%$0.03

MEDS

MEDS42

$7.49

arrow_drop_up0.52%$0.03

Performance History

Key Stats
Open	$7.26
Prev. Close	$7.46
EPS	-24.38
Dividend	-
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$13.28M
PE Ratio	-

	LOW	HIGH
Day Range	6.95	7.49
52 Week Range	3.69	44.56

Ratios







EPS	-24.38

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Trxade Group (MEDS)

Trxade Group Inc (MEDS) is a pharmaceutical services company that operates an online marketplace for independent pharmacies. The company's platform provides a wide range of products, including brand-name and generic pharmaceuticals, over-the-counter drugs, and medical supplies. By connecting independent pharmacies with wholesalers and manufacturers, Trxade Group aims to improve pricing transparency and help pharmacies reduce their costs. The company also offers additional services, such as a mobile app for ordering and managing inventory, a patient prescription discount card program, and a telemedicine platform.

One of the key advantages of Trxade Group's platform is its focus on the independent pharmacy market. Independent pharmacies often struggle to compete with larger retail chains due to higher purchasing costs and limited bargaining power. Trxade Group's marketplace allows these pharmacies to access a wide range of products at competitive prices, giving them the opportunity to improve their margins and attract more customers. The company has been steadily growing its user base and expanding its network of wholesalers and manufacturers, which has helped drive revenue growth in recent years.

Websitecall_made

Sector: Healthcare
Industry: Pharmaceutical Retailers
CEO: Mr. Surendra K. Ajjarapu
Headquarters: Lutz
Employees: 33
Exchange: NASDAQ

Keep an eye on Trxade Group

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Trxade Group 's (MEDS) price per share?

The current price per share for Trxade Group (MEDS) is $7.5. The stock has seen a price change of $0.04 recently, indicating a 0.52% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Trxade Group (MEDS)?

For Trxade Group (MEDS), the 52-week high is $44.56, which is 494.21% from the current price. The 52-week low is $3.69, the current price is 103.22% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Trxade Group (MEDS) a growth stock?

Trxade Group (MEDS) has shown an average price growth of 0.41% over the past three years. It has received a score of 14 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Trxade Group as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Trxade Group (MEDS) stock price performance year to date (YTD)?

As of the latest data, Trxade Group (MEDS) has a year-to-date price change of 40.17%. Over the past month, the stock has experienced a price change of -2.48%. Over the last three months, the change has been -47.26%. Over the past six months, the figure is -22.21%.

help

Is Trxade Group (MEDS) a profitable company?

Trxade Group (MEDS) has a net income of -$13.72M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 31.41% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -8K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $8.27M, although specific revenue growth data is currently not available. The gross profit is $2.6M. Operating income is noted at -$7.26M. Furthermore, the EBITDA is -$12.04M.

help

What is the market capitalization of Trxade Group (MEDS)?

Trxade Group (MEDS) has a market capitalization of $13.28M. The average daily trading volume is 13.64K, indicating the stock's liquidity and investor engagement.